Heart Defect Closure Devices Market

Heart defect closure devices are permanent implants designed to close defects between chambers of the heart or a patent ductus arteriosus. These are self-expandable, self-centering umbrella-like devices. The design and shape of the devices vary, as does their exact mode of deployment. They are implanted in the defect in a cardiac catheterization laboratory, through catheters inserted into either a vein or an artery (transcatheter or percutaneous approach). There are several types of defects, which include atrial septal defect (ASD), persistent patent ductus arteriosus (PDA), ventricular septal defect (VSD), patent foramen ovale (PFO), and left atrial appendage (LAA). Most of these defects are congenital, but can occur after a myocardial infarction or can be the result of a surgical repair of other congenital heart defects.

Heart Defect Closure Devices Market contains market size and forecasts of Heart Defect Closure Devices in global, including the following market information:

• Global Heart Defect Closure Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Heart Defect Closure Devices Market Sales, 2017-2022, 2023-2028, (Units)
• Global top five Heart Defect Closure Devices companies in 2021 (%)

The global Heart Defect Closure Devices market was valued at 355 million in 2021 and is projected to reach US$ 489.2 million by 2028, at a CAGR of 4.7% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

ASD Closure Devices Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Heart Defect Closure Devices include Abbott, Boston Scientific, LifeTech, Lepu Medical, Occlutech, W. L. Gore and Associates, Starway, Coherex Medical and Cardia and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Heart Defect Closure Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Heart Defect Closure Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global Heart Defect Closure Devices Market Segment Percentages, by Type, 2021 (%)

• ASD Closure Devices
• VSD Closure Devices
• PDA Closure Devices
• PFO Closure Devices
• LAA Closure Devices

Global Heart Defect Closure Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global Heart Defect Closure Devices Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics

Global Heart Defect Closure Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global Heart Defect Closure Devices Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Heart Defect Closure Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Heart Defect Closure Devices revenues share in global market, 2021 (%)
• Key companies Heart Defect Closure Devices sales in global market, 2017-2022 (Estimated), (Units)
• Key companies Heart Defect Closure Devices sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott
• Boston Scientific
• LifeTech
• Lepu Medical
• Occlutech
• W. L. Gore and Associates
• Starway
• Coherex Medical
• Cardia
• MicroPort